SHIH-PING (BOB) WANG

Profile

First Name

: SHIH-PING (BOB)

Middle Name

:

Last Name

: WANG

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
O2 MEDTECH INC
PAUL CHAN, GORDON HULL, JOHN PAVLIDIS, KEVIN ROONEY, WAYNE WU, ZENGPIN YU
EXECUTIVE OFFICER, DIRECTOR
ENDOSEE CORP
PAUL D. INDMAN, XIAOLONG (BRUCE) OUYANG, KEVIN ROONEY
EXECUTIVE OFFICER, DIRECTOR
QVIEW MEDICAL, INC.
RON HO, NICO KARSSEMEIJER, KEVIN K. ROONEY, WEI ZHANG
EXECUTIVE OFFICER, DIRECTOR
UROSEE CORP
XIAOLONG (BRUCE) OUYANG
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-04-06
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-23 
2017-03-13
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-24 
2015-03-12
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-28 
2014-11-10
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-28 
2014-07-16
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-28 
2014-06-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-16 
2014-01-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-16 
2013-10-01
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-28 
2013-06-07
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-28 
2013-02-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-11 
2011-11-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-10-31 
2011-10-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-09-30 
2011-03-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-02-22 
2010-05-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-05